Search Results 501-510 of 16572 for alopecia

1. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

   ... alopecia or toxicities that are stable and well-controlled and there is agreement to allow by the investigator and sponsor; Subject unable to receive both ...

2. Transforming Non-Invasive Liver Disease Detection by Magnetic Resonance Elastography - Mayo Clinic

   About this study. A variety of liver insults lead to pathological changes in liver architecture that culminate in cirrhosis. While invasive liver biopsy was ...

3. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

   03) except for alopecia, Grade 2 sensory neurotoxicity, or any other toxicity that in the opinion of the Investigator does not affect the assessment of ...

4. A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) - Mayo Clinic

   treatment-related grade >1 alopecia, treatment related grade 2 peripheral neuropathy, and treatment-related grade 2 hypothyroidism on a stable dose of ...

5. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   ... alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the ...

6. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Recovery to Grade 0-1, from adverse events related to prior anticancer therapy except alopecia, ≤ Grade 2 sensory neuropathy, lymphopenia, and ...

7. A Study to Evaluate the Safety of Lasofoxifene in Combination with Abemaciclib in Advanced or Metastatic ER+/HER2− Breast Cancer with ESR1 Mutation - Mayo Clinic

   ... alopecia and Grade 2 peripheral neuropathy before study entry. A washout period of at least 21 days is required between last chemotherapy dose and entry ...

8. Primary sclerosing cholangitis - Symptoms and causes - Mayo Clinic

   Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

9. A Study to Assess the Effectiveness and Safety of Durvalumab Alone or Combined with Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment - Mayo Clinic

   Patients with vitiligo or alopecia;; Patients with hypothyroidism (e.g., following Hashimoto syndrome), stable on hormone replacement;; Any chronic skin ...

10. A Study Comparing CAR-T Therapy Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants with Relapsed and Lenalidomide-Refractory Multiple Myeloma - Mayo Clinic

    Ongoing toxicity from previous anticancer therapy that has not resolved to baseline levels or to Grade 1 or less, except for alopecia,; Participants with ...